A Multicenter Study to Evaluate Safety and Efficacy of Specific Immunotherapy With Modified Allergen Extracts

NCT01012752 · clinicaltrials.gov ↗

PHASE3

Phase

UNKNOWN

Status

150

Enrollment

INDUSTRY

Sponsor class

Conditions

Allergic Rhinitis
Allergic Conjunctivitis

Interventions

BIOLOGICAL: modified allergen extract
BIOLOGICAL: Placebo

Sponsor

Roxall Medizin